HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dipesh Dhakal Selected Research

epothilone A

8/2022UPLC-PDA coupled HR-TOF ESI/MS2 -based identification of derivatives produced by whole-cell biotransformation of epothilone A using Nocardia sp. CS692 and a cytochrome P450 overexpressing strain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dipesh Dhakal Research Topics

Disease

7Neoplasms (Cancer)
12/2022 - 02/2018
1Hypoxia (Hypoxemia)
07/2020
1Stomach Neoplasms (Stomach Cancer)
07/2020
1Congenital Abnormalities (Deformity)
01/2020
1Obesity
05/2018

Drug/Important Bio-Agent (IBA)

2AnthracyclinesIBA
05/2018 - 02/2018
2Daunorubicin (Cerubidine)FDA LinkGeneric
05/2018 - 02/2018
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2018 - 02/2018
11,4-dihydroxyanthraquinone (quinizarin)IBA
12/2022
1Biological ProductsIBA
12/2022
1Excipients (Suspending Agents)IBA
08/2022
1epothilone AIBA
08/2022
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
08/2022
1tamarixetinIBA
06/2021
1QuercetinIBA
06/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2020
1Angiogenesis InhibitorsIBA
07/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1MacrolidesIBA
08/2019
1Anti-Bacterial Agents (Antibiotics)IBA
08/2019
1Immunosuppressive Agents (Immunosuppressants)IBA
08/2019
1Pharmaceutical PreparationsIBA
05/2018
1Hypoglycemic Agents (Hypoglycemics)IBA
05/2018

Therapy/Procedure

2Therapeutics
08/2022 - 08/2019